Clinical trial
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the…
NCT00425282 · SK Life Science, Inc., Industry · Completed
Key facts
| NCT number | NCT00425282 |
|---|---|
| Title | A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of RWJ-333369 as Adjunctive Therapy in Subjects With Partial Onset Seizures Followed by an Open-Label Extension Study. |
| Lead sponsor | SK Life Science, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Focal, Seizure Disorder, Complex Partial Seizures, Complex Partial |
| Intervention type | Drug |
| Interventions | RWJ-333369 |
| Enrollment | 566 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 22, 2007 |
| Last update posted | Jun 20, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: